Preclinical tests on novel Covid-19 vaccines

Pers / media: Activiteiten met een maatschappelijk belang › Popular

Description

Geert van den BogaartGeert van den Bogaart

The research group Molecular Immunology and Microbiology headed by Prof.dr. Geert van den Bogaart collaborates with the German company BaseClick to pre-clinically test new RNA-based coronavirus vaccines. For this, isolated immune cells from blood of healthy volunteers are studied to determine whether the vaccines correctly initiate the anti-viral immune response. This research specifically focuses on the activation of T-cells to recognize the Covid-19 virus.
Read more on the program

Periode22-jun.-2020

Media-aandacht

1

Media-aandacht

  • TitelPreclinical tests on novel Covid-19 vaccines
    Mate van erkenningInternational
    Media naam/outletUniversity of Groningen News on Covid-19 related research
    MediatypeWeb
    Land/RegioNetherlands
    Release datum22/06/2020
    BeschrijvingThe research group Molecular Immunology and Microbiology headed by Prof.dr. Geert van den Bogaart collaborates with the German company BaseClick to pre-clinically test new RNA-based coronavirus vaccines. For this, isolated immune cells from blood of healthy volunteers are studied to determine whether the vaccines correctly initiate the anti-viral immune response. This research specifically focuses on the activation of T-cells to recognize the Covid-19 virus.
    Read more on the program
    URLhttps://www.rug.nl/research/corona-publicaties/
    PersonenGeert van den Bogaart
Alle bekijken 1
Minder bekijken